Company intelligence / Profile preview

MyGenostics

Beijing, Beijing, Chinamygenostics.com ↗

Ownership: Private
Employees: ~750
Development stage: Other

Overview

MyGenostics provides high-throughput genetic testing solutions using proprietary gene capture technology combined with next-generation sequencing. They have developed over 400 personalized gene capture LDT and IVD kits, widely used for rare disease diagnosis, cancer drug guidance, and microbial identification. The company has published over 900 SCI papers and built one of the largest genetic disease databases in China.

Therapeutic areas: OncologyRare Diseases
Modalities: Diagnostic deviceNext-generation sequencing (NGS)Gene panel testingWhole exome sequencing (WES)Whole genome sequencing (WGS)
Industry: Molecular Diagnostics

Partnerships

Over 500 tertiary hospitals nationwide in Chinamore than 6,000 doctors>200 clinical labs serviced in China

Beyond the preview

Go deeper on MyGenostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyGenostics.

Explore the full profile